(Q43172183)

15 November 2017

title

Assessing the cost-effectiveness of drug and lifestyle intervention following opportunistic screening for pre-diabetes in primary care (English)

1 reference

cost-effectiveness analysis

15 November 2017

0 references

1 reference

M Y Bertram

1

1 reference

15 November 2017

S S Lim

series ordinal

2

1 reference

15 November 2017

J J Barendregt

series ordinal

3

1 reference

15 November 2017

T Vos

series ordinal

4

1 reference

15 November 2017

publication date

5 February 2010

1 reference

15 November 2017

1 reference

15 November 2017

volume

53

1 reference

15 November 2017

issue

5

1 reference

15 November 2017

page(s)

875-881

1 reference

Acarbose for the prevention of Type 2 diabetes, hypertension and cardiovascular disease in subjects with impaired glucose tolerance: facts and interpretations concerning the critical analysis of the STOP-NIDDM Trial data

15 November 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00125-010-1661-8

Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study

21 January 2018

1 reference

12 December 2020

Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006

1 reference

12 December 2020

Rural residents' utilisation of health and visiting specialist health services

1 reference

12 December 2020

Using an economic model of diabetes to evaluate prevention and care strategies in Australia

1 reference

12 December 2020

The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1).

1 reference

12 December 2020

The Diabetes Prevention Program (DPP): description of lifestyle intervention

1 reference

12 December 2020

Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience

1 reference

12 December 2020

Efficacy of acarbose in Chinese subjects with impaired glucose tolerance

1 reference

12 December 2020

Incidence and outcome of subtypes of ischaemic stroke: initial results from the north East melbourne stroke incidence study (NEMESIS).

1 reference

12 December 2020

Primary and subsequent coronary risk appraisal: new results from the Framingham study.

1 reference

12 December 2020

Risk factors for stroke mortality in men and women: The Busselton Study

1 reference

12 December 2020

Effects of weight loss with orlistat on glucose tolerance and progression to type 2 diabetes in obese adults

1 reference

12 December 2020

The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)--methods and response rates

1 reference

12 December 2020

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients

1 reference

12 December 2020

Cost-effectiveness analysis and the consistency of decision making: evidence from pharmaceutical reimbursement in australia (1991 to 1996)

1 reference

12 December 2020

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

12 December 2020

An alternative approach to projecting health expenditure in Australia

1 reference

12 December 2020

Burden of disease and injury in Australia in the new millennium: measuring health loss from diseases, injuries and risk factors.

1 reference

12 December 2020

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

1 reference

12 December 2020

Accessibility to general practitioners in rural South Australia. A case study using geographic information system technology

1 reference

12 December 2020

Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis

1 reference

12 December 2020

Effect of metformin on patients with impaired glucose tolerance.

1 reference

12 December 2020

A generic model for the assessment of disease epidemiology: the computational basis of DisMod II

1 reference

12 December 2020

Priority setting in health: origins, description and application of the Australian Assessing Cost–Effectiveness initiative

1 reference

12 December 2020

Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study.

1 reference

12 December 2020

Incidence of the Major Stroke Subtypes

1 reference

12 December 2020

Different strategies for screening and prevention of type 2 diabetes in adults: cost effectiveness analysis

1 reference

12 December 2020

10.1007/S00125-010-1661-8

Identifiers

DOI

1 reference

15 November 2017

1 reference